2018 annual financial data
INmune Bio 2018 Operating margin
INmune Bio 2018 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -12,440,023 USD and net income was -12,440,023 USD.
Operating cash flow was -2,058,994 USD.
Get free INmune Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -12,440,023 USD
- Net income
- -12,440,023 USD
- Operating cash flow
- -2,058,994 USD